Subscribe to RSS

DOI: 10.1055/s-0039-1678587
Superior Sagittal Sinus Invasion by Malignant Glioma: Case Report and Literature Review
Invasão do seio sagital superior por glioma maligno: Relato de caso e revisão da literaturaPublication History
27 October 2018
08 January 2019
Publication Date:
08 February 2019 (online)

Abstract
Anaplastic oligodendrogliomas (AOs) correspond to ∼ 23% of all oligodendrogliomas. They correspond to a tumor with malignant histological characteristics, focal or diffuse, associated with a worse prognosis. In the present case report, we describe the case of a 30-year-old female submitted to resection of a right parietal lesion whose histology showed to be an AO. She underwent complementary treatment with chemotherapy and radiotherapy according to the Roger Stupp protocol. Four years after the initial diagnosis, there was tumor recurrence within the superior sagittal sinus, with no evidence of recurrence elsewhere. In the literature, we have found no similar published case reinforcing the rarity of this condition
Resumo
Oligodendrogliomas anaplásicos correspondem a ∼ 23% de todos os oligodendrogliomas. Eles correspondem a um tumor com características histológicas malignas, focais ou difusas, associadas a um pior prognóstico. Descrevemos aqui o caso de uma mulher de 30 anos de idade submetida à ressecção de uma lesão parietal direita, cuja histologia mostrou ser um oligodendroglioma anaplásico. A paciente foi submetida a tratamento complementar com quimioterapia e radioterapia de acordo com o protocolo de Roger Stupp. Quatro anos após o diagnóstico inicial, ocorreu recidiva tumoral no seio sagital superior, sem evidência de recorrência em outro local. Na literatura, não encontramos nenhum caso semelhante publicado reforçando a raridade desta condição.
-
References
- 1 Simonetti G, Gaviani P, Botturi A, Innocenti A, Lamperti E, Silvani A. Clinical management of grade III oligodendroglioma. Cancer Manag Res 2015; 7: 213-223
- 2 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. (2016) World Health Organization Histological Classification of Tumours of the Central Nervous System. France: International Agency for Research on Cancer;
- 3 Central Brain Tumor Registry of the United States. Primary brain tumors in the United States. Statistical report. 1992–1997. 2000. Chicago, IL: Published by the Central Brain Tumor Registry of the United States;
- 4 Henderson KH, Shaw EG. Randomized trials of radiation therapy in adult low-grade gliomas. Semin Radiat Oncol 2001; 11 (02) 145-151
- 5 Rogers LR. Cerebrovascular complications in cancer patients. Neurol Clin 2003; 21 (01) 167-192
- 6 Vargo JA, Snelling BM, Ghareeb ER. , et al. Dural venous sinus thrombosis in anaplastic astrocytoma following concurrent temozolomide and focal brain radiotherapy plus bevacizumab. J Neurooncol 2011; 104 (02) 595-598